Prenetics Global Limited (PRE) Growth Rates Comparisons to Laboratory Analytical Instruments Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Prenetics Global Limited  (NASDAQ: PRE)
 

Prenetics Global Limited Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRE Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 210.67 % 4.41 % 7.83 % 9.17 %
Q / Q Revenue Growth (Q2 MRQ) 29.3 % 7.05 % 1.95 % 4.22 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 180.73 % 2.65 % 7.65 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 18.96 % 1.15 % 3.54 % 2.08 %
Revenue 5 Year Average Growth - 3.1 % 8.67 % 13.63 %


PRE's Growth Comparisons in II. Quarter 2026




Reporting 210.67% surge year on year in the second quarter 2026 Revenue, Prenetics Global Limited led the 4.41% growth in the Laboratory Analytical Instruments industry, and 7.83% growth in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Laboratory Analytical Instruments industry, Prenetics Global Limited reported above average market Sales growth.

Company's sequential top-line increase was 29.3% from the first quarter. Average annual sales rise for Prenetics Global Limited is %, while S & P 500's average yearly sales growth is 13.63% over the five years, including only Businesses with the second quarter 2026 Results.

PRE Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Goods transferred at a point in time
-
-
Services transferred at a point in time
-
-
Services transferred overtime
-
-
Prevention - genetic testing
-
-
Consumer health - health and wellness solutions
-
-
Consumer health - sports distribution
-
-
Prevention
-
-
Prevention segments
-
-
Consumer Health segments
-
-
Hong Kong
-
-
The United States
-
-
Discontinued operations
-
-
Discontinued operations Hong Kong
-
-
Discontinued operations United Kingdom
-
-
Discontinued operations Taiwan
-
-
Discontinued operations Rest of the world
-
-
Discontinued operations Services transferred at a point in time
-
-
Discontinued operations Diagnostics - sale of precision oncology services
-
-
Discontinued operations Prevention and Diagnostics
-
-
Discontinued operations ACT genomics
-
-
Discontinued operations ACT genomics Hong Kong
-
-
Discontinued operations ACT genomics United Kingdom
-
-
Discontinued operations ACT genomics Taiwan
-
-
Discontinued operations ACT genomics Rest of the world
-
-
Discontinued operations ACT genomics Services transferred at a point in time
-
-
Total
-
-


Growth Rates of PRE's Income in the second quarter 2026


PRE Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - -24.02 % 20.61 % 29.95 %
Sequential Operating Income Change (Q2 MRQ) - 162.37 % 3.83 % 4.5 %
Y / Y Operating Income Growth (Q2 TTM) - -5.67 % 37.39 % 14.37 %
Sequential Operating Income Growth (Q2 TTM) - -9.94 % 9.84 % 6.96 %
Operating Income 5 Year Avg. Change - -6.57 % 10.27 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - 175.66 % - 21.83 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) - - - 11.13 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - - -17.95 % 16.46 %
Sequential Income from Cont. Ops. Change (Q2 TTM) - 65.14 % -5.35 % 6.05 %
Income from Cont. Ops. 5 Year Avg. Change - -16.43 % 8.91 % -28.64 %

PRE Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - 173.35 % 14.04 % 21.56 %
Q / Q Net Income Growth (Q2 MRQ) - - -30.23 % 11.12 %
Y / Y Net Income Change (Q2 TTM) - - 54.29 % 16.59 %
Sequential Net Income Change (Q2 TTM) - 67.33 % 10.97 % 6.03 %
Net Income 5 Year Avg. Growth - -16.48 % 9.09 % 23.95 %

PRE's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - 184.86 % - 21.83 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - - - 11.13 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) - - - -99.7 %
EPS from Cont. Ops. 5 Year Avg. Growth - -21.32 % 8.91 % -28.64 %



PRE EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - 182.47 % 14.04 % -28.64 %
Q / Q EPS Net Growth (Q2 MRQ) - - -30.23 % 11.12 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - -99.97 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) - - - -99.87 %
EPS Net 5 Year Avg. Change - -16.48 % 9.09 % 23.95 %



Prenetics Global Limited reported bottom-line of $ 0.00 in the second quarter, compare to $ 0.00 in the same quarter a year ago. Laboratory Analytical Instruments industry grew by 182.47%, while Healthcare sector increased by 14.04%, and overall market improved by 21.56%.

The company's sequential bottom-line increase was 29.3% from the first quarter. Average annual income per share rise for Prenetics Global Limited is %, while S & P 500's average yearly income per share growth is 23.95% over the five years, including only Businesses with the second quarter 2026 earnings results.

PRE Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - -39.26 % -12.21 % 2 %
Sequential Free Cash Flow Change (Q2 MRQ) - -7.34 % -35.08 % 22.32 %
Y / Y Free Cash Flow Change (Q2 TTM) - -7.78 % 11.11 % 11.81 %
Sequential Free Cash Flow Change (Q2 TTM) - -5.62 % 2.15 % 2.41 %
Free Cash Flow 5 Year Avg. Change - -2.7 % 0.42 % 1.8 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - 214006.51 % -93.75 % 1035.72 %
Sequential Net Cash Flow Change (Q2 MRQ) - 125.42 % -99.16 % -
Y / Y Net Cash Flow Change (Q2 TTM) - - -23.37 % -
Sequential Net Cash Flow Change (Q2 TTM) - 318.89 % -25.17 % -
Net Cash Flow 5 Year Avg. Change - 16.21 % 6.46 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) -79.32 % 0.83 % 7.49 % 23.41 %
Sequential Capital Expenditures Change (Q2 MRQ) - 24.63 % 16.64 % 18.97 %
Y / Y Capital Expenditures Change (Q2 TTM) -79.32 % -4.71 % 11.98 % 23.88 %
Sequential Capital Expenditures Change (Q2 TTM) -79.32 % -0.13 % 7.46 % 7.02 %
Capital Expenditures 5 Year Avg. Change - 4.39 % 8.61 % 14.16 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.